| Literature DB >> 26641889 |
Zuzanna Pietralik1, Żaneta Kołodziejska1, Marek Weiss2, Maciej Kozak1,3.
Abstract
The success rate of gene therapy depends on the efficient transfection of genetic material into cells. The golden mean between harmlessness and high effectiveness can be provided by syntheticEntities:
Mesh:
Substances:
Year: 2015 PMID: 26641889 PMCID: PMC4671569 DOI: 10.1371/journal.pone.0144373
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Chemical structures of studied gemini surfactants, i.e., alkoxyderivatives of bis-imidazolium quaternary salts with different-length hydrophobic side chains (m = 5, 6, 7, 8, 9, 11, 12, 14, 16).
Fig 2Agarose gel electrophoresis results.
Images obtained for lipoplexes based on C12 gemini surfactant and duplex DNA consisting of 21 bp (a) and for lipoplexes based on C12 gemini surfactant and high-molecular-weight salmon-sperm DNA consisting of 20 kbp.
Summary of the results of electrophoretic experiments on the studied series of gemini surfactants and all nucleic acids tested, demonstrating the relationship between the charge ratio p/n characterizing the systems and the formation of stable complexes.
Denotation 20 kbp indicates the complete complex formation in the case of 20 kbp salmon-sperm DNA, denotation shows under which conditions complexes were formed with low-molecular-weight salmon-sperm DNA (185 bp), and denotation 21 bp designates the complexes in systems with the smallest tested nucleic acids (both 21 bp DNA and RNA).
|
| C5 | C6 | C7 | C8 | C9 | C11 | C12 | C14 | C16 |
|---|---|---|---|---|---|---|---|---|---|
| 0.5 | - | - | - | - | - | - | - | - | - |
| 0.75 | - | - | - | - | - | - | - | - | - |
| 1 | - | - | - | - | - | - | - | - | - |
| 2 | - | - | - | - | - | - | - | - | - |
| 3 | - | - | - | - | - | - | - | - | - |
| 4 | - | - | - | - | - | - |
| - | - |
| 5 | - | - | - | - | - |
|
|
|
|
| 6 | - | - | - | - | - |
|
|
|
|
| 8 | - | - | - | - | - |
|
|
|
|
| 10 | - | - | - | - | - |
|
|
|
|
| 12 | - | - | - | - | - |
|
|
|
|
| 14 | - | - | - | - |
|
|
|
|
|
| 16 | - | - | - | - |
|
|
|
|
|
| 18 | - | - | - | - |
|
|
|
|
|
| 20 | - | - | - | - |
|
|
|
|
|
| 25 | - | - | - | - |
|
|
|
|
|
| 30 | - | - | - | - |
|
|
|
|
|
| 35 | - | - | - | - |
|
|
|
|
|
| 40 | - | - | - | - |
|
|
|
|
|
Fig 3Agarose gel electrophoresis of lipoplexes based on C9 surfactant with high-molecular-weight salmon-sperm DNA (20 kbp).
Summary of the lowest p/n values and concentrations of surfactant for which 100% complexes are created.
| RNA 21bp | DNA 21bp | DNA 185bp | DNA 20kbp | |||||
|---|---|---|---|---|---|---|---|---|
| Surfactant |
| M [mM] |
| M [mM] |
| M [mM] |
| M [mM] |
| C11 | 8 | 3.2 | 8 | 3.2 | 5 | 2 | 4 | 1.6 |
| C12 | 5 | 2 | 5 | 2 | 4 | 1.6 | 4 | 1.6 |
| C14 | 12 | 4.8 | 12 | 4.8 | 8 | 3.2 | 5 | 2 |
| C16 | 10 | 4 | 10 | 4 | 8 | 3.2 | 5 | 2 |
Fig 4CD spectra of lipoplexes based on C14 and low-molecular-weight DNA under conditions ensuring complexation (b) and for lower p/n ratios (a).
Fig 5CD spectra of lipoplexes with low-molecular-weight DNA (185 base pairs).
Lipoplexes based on surfactant C11 (a), C12 (b), C14 (C) and C16 (d) at different p/n ratios. For reasons of clarity, only selected spectra are plotted, and dotted lines were used for spectra after reaching the complexation level (those spectra are denoted based on electrophoresis results).
Fig 6CD spectra of lipoplexes with high-molecular-weight DNA (20 kbp).
Lipoplexes based on surfactant C11 (a), C12 (b), C14 (C) and C16 (d) at different p/n ratios. For reasons of clarity, only selected spectra are plotted, and dotted lines were used for spectra after reaching the complexation level (denoted based on electrophoresis results). The dependence of the system’s charge ratios on the location of the positive band of CD spectra for surfactants with the longest aliphatic side chains (C12, C14 and C16) (e).
Fig 7Selected CD spectra of C12 gemini surfactant with two types of oligonucleotides.
Duplex DNA of 21 bp (a) and siRNA– 21 bp (b).
Fig 8AFM topography of lipoplexes based on C12 (p/n = 6) and DNA (20 kbp).
(a) Phase image of lipoplexes, (b) topography image of lipoplexes, (c) 3D topography of DNA reference solution (20 kbp), (d) 3D topography of complex, (e) AFM topography of DNA with cross-sections of DNA structure, (f) topography of lipoplexes with cross-sections of formed complexes, and (g) cross-sections of DNA and lipoplexes.
Fig 9AFM results of lipoplexes based on C6 surfactant.
AFM images of system based on C6 surfactant at a p/n ratio of 0.75 and high -MW DNA for which complex formation was not detected. On the left (a), AFM topography of observed extended structures and phase image on the right (b). The dark fields probably consist of DNA molecules, which are surrounded by surfactant molecules/bright fields. Below AFM images of lipoplex based on surfactant C12 and DNA oligonucleotide at p/n = 5. 3D view (c) and topography with marked cross-section (d).
Fig 10Results of cytotoxicity tests.
Selected images of HeLa cells without any treatment (reference sample) and after exposure to solutions of gemini surfactants (C11 and C16), at different concentrations. Below, the dependence of absorbance measured at 570 nm on surfactants concentration, after MTT assay with fitted Boltzmann models.